Radiation-Induced Myelosuppression Treatment Market: Roll-out of New Product Turns out to Be the Developmental Strategy
Clinically instrumental myelosuppression may occur in patients undergoing treatment to smaller radiotherapy fields who have received chemotherapy before or in the course of therapy. As such, unscheduled interruptions in radiotherapy have been linked with a constrained probability of local control of tumors of the breast, lung, uterine cervix and upper aerodigestive tract. There is every possibility tumor cells will repopulate robustly in the course of breaks in treatment and subsequently become complex to obliterate. In wake of this, radiation oncologists...
View full press release